Selected article for: "efficacy trial and vaccine trial"

Author: Connors, Mark; Graham, Barney S.; Lane, H. Clifford; Fauci, Anthony S.
Title: SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn
  • Cord-id: uzbkde42
  • Document date: 2021_1_19
  • ID: uzbkde42
    Snippet: As COVID vaccines roll out, internists and other health care providers are being turned to as trusted sources of information for patients and communities. Here, experts from NIAID outline the current state of knowledge regarding such vaccines. They contrast vaccine platforms, summarize clinical trial data regarding efficacy and safety, and comment on key questions including the ability of current vaccines to protect against infection and to decrease the prevalence of virus in the community.
    Document: As COVID vaccines roll out, internists and other health care providers are being turned to as trusted sources of information for patients and communities. Here, experts from NIAID outline the current state of knowledge regarding such vaccines. They contrast vaccine platforms, summarize clinical trial data regarding efficacy and safety, and comment on key questions including the ability of current vaccines to protect against infection and to decrease the prevalence of virus in the community.

    Search related documents:
    Co phrase search for related documents
    • additional study and adequate level: 1
    • adenoviral vaccine and low seroprevalence: 1, 2